CGI-1746

CAT: 0804-HY-11999-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-11999-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CGI-1746 is a potent and highly selective inhibitor of the Btk with IC50 of 1.9 nM.
CAS Number
[910232-84-7]
UNSPSC
12352005
Hazard Statement
H302
Target
Autophagy; Btk
Type
Reference compound
Related Pathways
Autophagy; Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/CGI-1746.html
Concentration
10mM
Purity
99.39
Solubility
DMSO : ≥ 50 mg/mL
Smiles
O=C(C1=CC=C(C=C1)C(C)(C)C)NC2=CC=CC(C(N=C3NC4=CC=C(C=C4)C(N5CCOCC5)=O)=CN(C3=O)C)=C2C
Molecular Formula
C34H37N5O4
Molecular Weight
579.69
Precautions
H302
References & Citations
[1]Di Paolo, Julie A. et al. Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis. Nature Chemical Biology (2011), 7 (1), 41-50|[2]Kokabee L, et al. Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer. Cancer Biol Ther. 2015;16 (11) :1604-15
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-18016CGI 560
HY-10845CGI-17341
HY-P88876FAM164A (CGI 62) Antibody (YA8560, Mouse)
HY-117181UK-1745
HY-19976-01RN-1747
HY-W770090CF 1743-d7
HY-176241DC-174
HY-178005EGFR-IN-174
HY-117868NC-174
HY-161826Antitumor agent-174

Alternative Products

CatalogName
6965/10CGI 1746
A3302-100CGI-1746
SC1184-10mMCGI-1746 (BTK inhibitor)
S0B1196-01TRPV4 Recombinant Rabbit mAb (S-1746-65)
TR313450DLX2 Human shRNA Plasmid Kit (Locus ID 1746)
SR301217DLX2 Human siRNA Oligo Duplex (Locus ID 1746)
TL313450VDLX2 Human shRNA Lentiviral Particle (Locus ID 1746)
MBS5776713CGI-17341
PE4000302-01CGI Panel
244646CGI-14 (Amidohydrolase Domain Containing 2, CGI-14)

Popular Products